Drug-coated balloon (DCB) technology was developed to deliver the antiproliferative drugs
to the vessel wall without leaving any permanent prosthesis or durable polymers. The …

Continuous loss of cardiomyocytes (CMs) is one of the fundamental characteristics of many
heart diseases, which eventually can lead to heart failure. Due to the limited proliferation …

The Japanese Percutaneous Coronary Intervention (J-PCI) registry is endorsed by the
Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) and is …

Background: Acute coronary syndrome (ACS) hospital survivors experience a wide array of
late adverse cardiac events, despite considerable advances in the quality of care. We …

Background Recently, the impact of the lack of standard modifiable risk factors, including
hypertension, diabetes, dyslipidaemia, and current smoking, has been investigated in ST …

The situation around primary percutaneous coronary intervention (PCI) has dramatically
changed since coronavirus disease 2019 (COVID-19) pandemic. The impact of COVID-19 …

Background Identification of and therapeutic approaches to standard modifiable risk factors
(SMuRFs), including hypertension, diabetes, dyslipidemia, and smoking, have led to …

Acute myocardial infarction (MI) is one of the major scenarios of extracorporeal membrane
oxygenation (ECMO) use. The utilization of mechanical circulatory support systems …

Background Acute myocardial infarction (AMI) in young patients is a concerning issue
because of its adverse health and social impacts. Nevertheless, risk factors and prognosis of …

Background: With the rapid spread of COVID-19, hospitals providing percutaneous coronary
intervention (PCI) were placed in unique and unfamiliar circumstances. This study evaluated …